Skip to main content

Sierra Oncology, Inc.

SRRADelisted Jul 1, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001290149

Sierra Oncology, Inc. was delisted on Jul 1, 2022; its insiders filed their last Form 4 on Jul 1, 2022; 109 institutions reported holding it in 13F filings for Q2 2022, worth $1.23B in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Sierra Oncology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
+9 vs. Q3 2021
Shares held
12.3M
+1.65M (+15.5%) vs. Q3 2021
Total value
$267.1M
+$34.1M (+14.6%) vs. Q3 2021
New holders
13
15 more added
Sold out
4
6 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SRRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 46 institutions
Q1 2021: 33 institutionsQ2 2021: 34 institutionsQ3 2021: 37 institutionsQ4 2021: 46 institutionsQ1 2022: 75 institutionsQ2 2022: 109 institutionsQ3 2022: 1 institutionQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $267.1M
Q1 2021: $149.7MQ2 2021: $171.8MQ3 2021: $233.1MQ4 2021: $267.1MQ1 2022: $655.0MQ2 2022: $1.23BQ3 2022: $4.00KQ4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SRRA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20221$4.00K
Q2 2022109$1.23B
Q1 202275$655.0M
Q4 202146$267.1M
Q3 202137$233.1M
Q2 202134$171.8M
Q1 202133$149.7M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Sierra Oncology, Inc.; share changes are against Q3 2021.

Institutions holding SRRA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Group One Trading, L.P.212$5.00K0.00%00.0%Unchanged
Rise Advisors, LLC250$5.43K0.01%+250New
Bank of America Corp616$13.0K0.00%+616New
Advisor Group Holdings, Inc.836$18.0K0.00%−23−2.7%Reduced
Elmwood Wealth Management, Inc.1,140$25.0K0.01%+1,140New
Wells Fargo & Company1,200$26.0K0.00%00.0%Unchanged
JPMorgan Chase & Co1,300$28.0K0.00%+1,200+1,200.0%Added
Tower Research Capital LLC (TRC)1,305$28.0K0.00%+1,305New
Signaturefd, LLC2,500$54.0K0.00%00.0%Unchanged
Royal Bank of Canada2,740$59.0K0.00%+612+28.8%Added
Acadian Asset Management LLC3,668$79.0K0.00%+3,668New
Citigroup Inc7,344$160.0K0.00%+7,344New
Gyon Technologies Capital Management, LP9,631$209.0K0.04%+9,631New
Geode Capital Management, LLC10,075$219.0K0.00%00.0%Unchanged
Morgan Stanley10,206$222.0K0.00%+10,173+30,827.3%Added
Crescent Grove Advisors, LLC17,786$387.0K0.04%+17,786New
683 Capital Management, LLC17,856$388.0K0.02%+17,856New
BlackRock Inc.23,445$509.0K0.00%+2,988+14.6%Added
Northern Trust Corp38,712$842.0K0.00%−118−0.3%Reduced
Dimensional Fund Advisors LP39,305$854.0K0.00%+16,208+70.2%Added
Two Sigma Investments, LP52,523$1.14M0.00%+30,122+134.5%Added
Nan Fung Group Holdings Ltd52,979$1.15M0.34%00.0%Unchanged
Bridgeway Capital Management, LLC60,507$1.31M0.02%00.0%Unchanged
Two Sigma Advisers, LP61,756$1.34M0.00%+19,100+44.8%Added
Boothbay Fund Management, LLC67,286$1.46M0.05%+9,514+16.5%Added
Acuta Capital Partners, LLC68,500$1.49M0.63%+68,500New
Pura Vida Investments, LLC71,320$1.55M0.16%−2,313−3.1%Reduced
Polar Asset Management Partners Inc.85,900$1.87M0.02%+85,900New
Sio Capital Management, LLC95,450$2.08M0.63%00.0%Unchanged
Renaissance Technologies LLC111,035$2.41M0.00%+5,761+5.5%Added
Opaleye Management Inc.165,778$3.60M0.76%00.0%Unchanged
Silverarc Capital Management, LLC192,045$4.17M1.87%+28,559+17.5%Added
Sofinnova Investments, Inc.212,281$4.62M0.30%+5,717+2.8%Added
Ghost Tree Capital, LLC250,000$5.43M2.08%+50,000+25.0%Added
Caxton Corp262,969$5.72M4.67%−179,785−40.6%Reduced
Vanguard Group Inc275,458$5.99M0.00%+46,200+20.2%Added
New Leaf Venture Partners, L.L.C.409,611$8.90M3.23%00.0%Unchanged
Paradigm Biocapital Advisors LP474,945$10.3M2.95%+474,945New
Ikarian Capital, LLC569,029$12.4M3.54%−4,351−0.8%Reduced
Deep Track Capital, LP607,600$13.2M0.98%+607,600New
Abingworth LLP876,656$19.1M4.62%00.0%Unchanged
Rock Springs Capital Management LP1,184,793$25.8M0.60%−129,204−9.8%Reduced
Adage Capital Partners GP, L.L.C.1,230,468$26.8M0.05%+87,438+7.6%Added
Frazier Management LLC1,264,861$27.5M2.12%+460,194+57.2%Added
OrbiMed Advisors LLC1,477,320$32.1M0.42%00.0%Unchanged
Vivo Capital, LLC1,917,074$41.7M2.51%00.0%Unchanged
Millennium Management LLC0$00.00%−98,131−100.0%Sold out
Jackson Square Capital, LLC0$00.00%−9,152−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−41−100.0%Sold out
Brewin Dolphin Ltd0$00.00%−24−100.0%Sold out